Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer-Reference-Cited by-同舟云学术

Trastuzumab Adjuvant Chemotherapy and Cardiotoxicity in Real-World Women With Breast Cancer

Published:2012-02 Issue:2 Volume:18 Page:113-119
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Tarantini Luigi,Cioffi Giovanni,Gori Stefania,Tuccia Fausto,Boccardi Lidia,Bovelli Daniella,Lestuzzi Chiara,Maurea Nicola,Oliva Stefano,Russo Giulia,Faggiano Pompilio

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference37 articles.

1. GLOBOCAN 2008, cancer incidence and mortality worldwide: IARC cancerbase no. 10;Ferlay,2010

2. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer;Slamon;Science,1989

3. HER2 amplification ratios by fluorescence in situ hybridization and correlation with immunohistochemistry in a cohort of 6556 breast cancer tissues;Owens;Clin Breast Cancer,2004

4. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987

5. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer;Andrulis;J Clin Oncol,1998

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frequency of and sex differences in cancer treatment-related cardiac dysfunction in trastuzumab-treated patients with salivary gland cancer: a retrospective cohort study;Cardio-Oncology;2024-07-17

2. HER2-Targeted Therapy—From Pathophysiology to Clinical Manifestation: A Narrative Review;Journal of Cardiovascular Development and Disease;2023-12-06

3. Is dyslipidemia a risk factor for trastuzumab-induced cardiotoxicity in breast cancer patients? A systematic review and meta-analysis;Revista Portuguesa de Cardiologia;2023-12

4. Correlation of High-Sensitivity Cardiac Troponin I Values and Cardiac Radiation Doses in Patients with Left-Sided Breast Cancer Undergoing Hypofractionated Adjuvant Radiotherapy with Concurrent Anti-HER2 Therapy;Current Oncology;2023-10-06